Correlation Between Viridian Therapeutics and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Keros Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Keros Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Keros Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Viridian and Keros is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Keros Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Keros Therapeutics. In addition to that, Viridian Therapeutics is 1.17 times more volatile than Keros Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Keros Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 5,621 in Keros Therapeutics on August 27, 2024 and sell it today you would lose (29.00) from holding Keros Therapeutics or give up 0.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Keros Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Keros Therapeutics |
Viridian Therapeutics and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Keros Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |